Worldwide Biotech/Biopharma Executives (From Nov. 7 to Nov. 2, 2012)

On Nov. 7, 2012, Array BioPharma Inc. announced John A. Orwin, chief executive officer of Affymax, Inc., joined the Company's board of directors.

On Nov. 6, 2012, Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (APRI) announced that Bassam Damaj, Ph.D., has resigned as a Director, President, and Chief Executive Officer of the Company and that Steve Martin, Senior Vice President and Chief Financial Officer, has been appointed interim Chief Executive Officer.

On Nov. 6, 2012, PTC Therapeutics, Inc. (PTC) announced the appointment of Geoffrey McDonough, M.D., to the company's Board of Directors who is the President and Chief Executive Officer of Swedish Orphan Biovitrum AB (Sobi).

On Nov. 2, 2012, Vical Incorporated (Nasdaq:VICL) announced the appointment of Mammen P. "Anza" Mammen, Jr., M.D., as Vice President, Clinical Vaccines.

On Nov. 2, 2012, Nextera announced the appointment of Thomas Andersen as new CEO who has significant business development experience from the pharmaceutical and biotech industry.